Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Glenn F. Pierce
Leeftijd : 65
Vermogen : 852 107 USD
Belangrijkste bedrijven : Global Blood Therapeutics, Inc. - Voyager Therapeutics, Inc.
Overzicht 
Glenn F. Pierce occupies the position of Chief Scientific Officer & Director at Voyager Therapeutics, Inc. and Chief Medical Officer & Senior Vice President of Bioverativ Therapeutics, Inc. Dr. Pierce is also on the board of World Federation of Hemophilia and Global Blood Therapeutics, Inc. and Member of American Society of Hematology, Member of The International Society On Thrombosis & Haemostasis and Member of Hemostasis & Thrombosis Research Society.

In the past Glenn F. Pierce held the position of Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc., Chief Medical Officer at Ambys Medicines, Inc., Principal at Amgen, Inc., Vice President-Therapeutic Product Development at Selective Genetics, Inc. and Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. (a subsidiary of Selective Genetics, Inc.), Vice President-Research & Clinical Development at Avigen, Inc., Vice President-Applied Research Hematology at Bayer Healthcare LLC and President for National Hemophilia Foundation.

Glenn F. Pierce received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from Washington University in St. Louis.


Posities en verantwoordelijkheden van Glenn F. Pierce 
NaamTitel Van
Global Blood Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2016
Voyager Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chief Scientific Officer & Director 2021
Bioverativ Therapeutics, Inc. Chief Medical Officer & Senior Vice President 2009
World Federation of Hemophilia Director 2015
American Society of Hematology Member -
The International Society On Thrombosis & Haemostasis Member -
Hemostasis & Thrombosis Research Society Member -


Belangnemingen van Glenn F. Pierce 
NaamAandelen%Totale waarde
Global Blood Therapeutics, Inc. (GBT)
(Biotechnologie & Medisch Onderzoek)
22 8370,037%834 007 USD
Voyager Therapeutics, Inc. (VYGR)
(Biotechnologie & Medisch Onderzoek)
5 0000,013%18 100 USD


Glenn F. PiercePersoonlijk netwerk 
Meest gelezen nieuws 
24/11ELON MUSK : Musk verkoopt Tesla-aandelen ter waarde van $1,05 mrd, koopt 2,15 mln aandelen
MR
06/12MUKESH AMBANI : Indiase verkopers dreigen met leveringsonderbrekingen uit protest tegen Reliance
MR
30/11JACK DORSEY : Jack Dorsey jaagt crypto, fintech droom post Twitter
MR
24/11JAMIE DIMON : Jamie Dimon grapt dat JPMorgan langer meegaat dan de communistische partij van China
MR
01/12JACK DORSEY : Dorsey-leiding Square verandert in Block met knipoog naar blockchain
MR
24/11ERIK NORDSTROM : Nordstrom-winst blijft achter bij ramingen door problemen met bevoorrading, aandelen kelderen
MR
03/12TILMAN FERTITTA : FAST Acquisition weigert fusie SPAC met Fertitta Entertainment te beëindigen
MR
29/11ANIL AMBANI : Indiase centrale bank start faillissementsprocedure tegen Reliance Capital; co moet voldoen
MR
23/11STUART ROSE : Morrisons aandeelhouders steunen CD&R's $10 mrd overname
MR
03/12ELON MUSK : Elon Musk verkoopt nog meer aandelen Tesla
AM
Meer nieuws


© 2021 People and Ownership :   
Glenn F. Pierce Verbindingen